E(1F&k2G(1F&l1H&n11WdLetterhead&l7C&a200CType=%(Type)s;npat=%(npat)s;pfx=%(pfx)s  ;pnom=%(pnom)s            ;prn=%(prn)s              ;cmed=%(cmed)s;numdos=1%(cprl)s507618 ;gmed=    ;
&a200Cnommed=%(nommed)s                  ;adm1=%(adm1)s                ;
&a200Cadm2=%(ad2)s                         ;adm3=                                        ;datedos=%(datedos)s;
&a200Cccor=        ;nomcor=                                        ;
&a-4R(s0p10h12v0s0b3T(1F                                                                    (s0p16h8.v0s0b3T(1F p1/1  (s0p10h12v0s0b3T(1F 






&a12R
                                            %(nommed)s                  
                                            %(adm1)s                
                                            %(ad2)s                         
  %(pfx)s   %(pnom)s %(prn)s                                                    
  NJF:                    DN:14/07/28
  %(ad1)s                        
  %(ad2)s                                Besan\on, le %(datedos)s @ 13H31
  Dossier N[ 1%(cprl)s507618 du(s0p10h12v0s3b3T(1F %(datedos)s                                        (s0p10h12v0s0b3T(1F 


    (s1p16v0s4101T(1F                                           B I O C H I M I E       (s0p10h12v0s0b3T(1F
   (s0p16h8.v0s0b3T(1F                              (Analyseur VITROS 250 -ORTHO-CLINICAL DIAGNOSTICS)        (s0p10h12v0s0b3T(1F
                                                         (s0p16h8.v0s0b3T(1F  R{f{rence           Ant{rieurs        (s0p10h12v0s0b3T(1F
                                                                        (s0p16h8.v0s0b3T(1F01/06/13 (s0p10h12v0s0b3T(1F
   UREE . . . . . . . . . . . . .       0,33 g/l       (s0p16h8.v0s0b3T(1F   0,19 @ 0,43    (s0p10h12v0s0b3T(1F      (s0p16h8.v0s0b3T(1F   0,41 (s0p10h12v0s0b3T(1F
                                        5,48 mmol/l    (s0p16h8.v0s0b3T(1F   3,15 @ 7,14    (s0p10h12v0s0b3T(1F
    (s0p16h8.v0s0b3T(1FTechnique enzymatique r{actifs ORTHO sur Vitros350 (s0p10h12v0s0b3T(1F
                                                                        (s0p16h8.v0s0b3T(1F30/12/13 (s0p10h12v0s0b3T(1F
   CREATININE . . . . . . . . . .        9,0 mg/l      (s0p16h8.v0s0b3T(1F    7,0 @ 13,0    (s0p10h12v0s0b3T(1F      (s0p16h8.v0s0b3T(1F    9,0 (s0p10h12v0s0b3T(1F
                                       79,65 umol/l    (s0p16h8.v0s0b3T(1F  61,95 @ 115,05  (s0p10h12v0s0b3T(1F
    (s0p16h8.v0s0b3T(1FTechnique enzymatique r{actifs ORTHO calibr{s/meth.de r{f.IDMS sur VITROS350 (s0p10h12v0s0b3T(1F
   Clairance cr{atinine MDRD           80,20 ml/mn
                                                                        (s0p16h8.v0s0b3T(1F01/06/13 (s0p10h12v0s0b3T(1F
   ALBUMINE PLASMATIQUE  . .        *     38 g/l       (s0p16h8.v0s0b3T(1F     39 @ 50      (s0p10h12v0s0b3T(1F      (s0p16h8.v0s0b3T(1F     37 (s0p10h12v0s0b3T(1F
                                                       (s0p16h8.v0s0b3T(1F                  (s0p10h12v0s0b3T(1F
(s0p16h8.v0s0b3T(1F (s0p10h12v0s0b3T(1F 
(s0p16h8.v0s0b3T(1F  / (s0p10h12v0s0b3T(1F &a69R&a58C(s0p16h8.v0s0b3T(1F r{sultats RECTOVERSO(s0p10h12v0s0b3T(1F 
&a71R&a10C(s0p16h8.v0s0b3T(1F (s0p10h12v0s0b3T(1F &a71R&a33.5C(s0p16h8.v0s0b3T(1F Biologiste M{dical(s0p10h12v0s0b3T(1F &a71R&a61C(s0p16h8.v0s0b3T(1F J.ALMARCHA(s0p10h12v0s0b3T(1F               &a200Cff##